Hepatotoxicity

Fillmore and his collaborators have focused on improving the identification of hepatic immune-related adverse events associated with immune checkpoint inhibitor therapy. His work involved the development of a rule-based algorithm designed to detect moderate to severe liver toxicity within large patient datasets. This methodology offers greater diagnostic accuracy than individual clinical review, providing a more reliable framework for monitoring hepatotoxicity in oncology patients.